Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac (CVAC) Invested Capital (2019 - 2024)

Historic Invested Capital for CureVac (CVAC) over the last 6 years, with Q4 2024 value amounting to $786.0 million.

  • CureVac's Invested Capital rose 3074.42% to $786.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $786.0 million, marking a year-over-year increase of 3074.42%. This contributed to the annual value of $786.0 million for FY2024, which is 3074.42% up from last year.
  • According to the latest figures from Q4 2024, CureVac's Invested Capital is $786.0 million, which was up 3074.42% from $601.2 million recorded in Q4 2023.
  • CureVac's Invested Capital's 5-year high stood at $914.0 million during Q4 2020, with a 5-year trough of $587.0 million in Q4 2022.
  • For the 5-year period, CureVac's Invested Capital averaged around $741.8 million, with its median value being $786.0 million (2024).
  • Its Invested Capital has fluctuated over the past 5 years, first surged by 217197.48% in 2020, then crashed by 2847.26% in 2022.
  • CureVac's Invested Capital (Quarter) stood at $914.0 million in 2020, then dropped by 10.22% to $820.6 million in 2021, then decreased by 28.47% to $587.0 million in 2022, then increased by 2.42% to $601.2 million in 2023, then skyrocketed by 30.74% to $786.0 million in 2024.
  • Its last three reported values are $786.0 million in Q4 2024, $601.2 million for Q4 2023, and $587.0 million during Q4 2022.